Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis

Anterior optic pathway pathology in CNS demyelinating diseases

(2022) Marco Pisa et al.   BRAIN

Early Aggressive Treatment Approaches for Multiple Sclerosis

(2021) Alexandra Simpson et al.   Current Treatment Options in Neurology

Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis

(2021) Jeffrey Lambe et al.   NEUROLOGY

Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study

(2021) K. Hänninen et al.   JOURNAL OF NEUROLOGY

Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis

(2021) Tim Spelman et al.   JAMA Neurology

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

(2021) Cecilia Smith Simonsen et al.   Frontiers in Neurology

Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study

(2021) Friedemann Paul et al.   Annals of Clinical and Translational Neurology

Retinal thinning and brain atrophy in early MS and CIS

(2020) Max Borgström et al.   ACTA NEUROLOGICA SCANDINAVICA

Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy

(2020) Elias S. Sotirchos et al.   ANNALS OF NEUROLOGY

Retinal measurements predict 10-year disability in multiple sclerosis

(2019) Alissa Rothman et al.   Annals of Clinical and Translational Neurology

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

(2019) Katharine Harding et al.   JAMA Neurology

Optimal Inter-Eye Difference Thresholds by OCT in MS: An International Study

(2019) Rachel C. Nolan et al.   ANNALS OF NEUROLOGY

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis

(2018) Bernard M. J. Uitdehaag   CNS DRUGS

Disease-modifying treatments for early and advanced multiple sclerosis

(2018) Gavin Giovannoni   CURRENT OPINION IN NEUROLOGY

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome

(2018) Hanna G. Zimmermann et al.   JAMA Neurology

Multiple sclerosis - a review

(2018) R. Dobson et al.   EUROPEAN JOURNAL OF NEUROLOGY

Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis

(2018) Frederike C. Oertel et al.   Expert Review of Neurotherapeutics

Evolving concepts in the treatment of relapsing multiple sclerosis

(2017) Giancarlo Comi et al.   LANCET

The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients

(2017) Anna M Pietroboni et al.   Multiple Sclerosis Journal

Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS

(2017) Ruggero Capra et al.   Multiple Sclerosis Journal

The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients

(2017) Anna M Pietroboni et al.   Multiple Sclerosis Journal

Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS

(2017) Ruggero Capra et al.   Multiple Sclerosis Journal

Brain Parenchymal Fraction in Healthy Adults—A Systematic Review of the Literature

(2017) Mattias Vågberg et al.   PLoS One

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

(2016) Elena H Martinez-Lapiscina et al.   LANCET NEUROLOGY

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

(2016) Massimo Filippi et al.   LANCET NEUROLOGY

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies

(2016) Andrés Cruz-Herranz et al.   NEUROLOGY

Rituximab in multiple sclerosis

(2016) Jonatan Salzer et al.   NEUROLOGY

Brain health: time matters in multiple sclerosis

(2016) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

(2015) Shiv Saidha et al.   ANNALS OF NEUROLOGY

Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes

(2015) Yu-Min Huang-Link et al.   Journal of Clinical Neurology

Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis

(2012) M. Vågberg et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis

(2011) Stephanie B. Syc et al.   BRAIN

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis

(2010) Axel Petzold et al.   LANCET NEUROLOGY

Rapid magnetic resonance quantification on the brain: Optimization for clinical usage

(2008) J.B.M. Warntjes et al.   MAGNETIC RESONANCE IN MEDICINE

RETINAL NERVE FIBER LAYER IS ASSOCIATED WITH BRAIN ATROPHY IN MULTIPLE SCLEROSIS

(2008) P. Villoslada et al.   NEUROLOGY